Amarin Corp Plc (AMRN)

[sts66]

Shades of MRC emerge as another biotech is attacked - a whistleblower claim has been filed against AZ drug biotech SAVA, saying they a guilty of scientific misconduct, mentions they're in the same league with the Theranos scandal. Stock cratered last night AH and today, from almost $120 to $80 on huge volume. I've been reading the CP filed with FDA asking them to halt the coming P3 trial and SAVA's almost instant rebuttal released this morning, they must have worked all night on this (no silence from them, whereas AMRN never confronted MRC). Don't know what to think - appears to be a short attack disguised as a whistleblower suit. Links to the CP and other docs:

https://www.regulations.gov/docket/FDA-2021-P-0930/document

Whaddya know - our old enemy AF is involved too:

https://www.statnews.com/2021/07/30/alzheimers-scientists-critique-cassava-sciences-study-results-overblown-inappropriate-uninterpretable/

Initial SA news blurb this morning:

https://seekingalpha.com/news/3733865-cassava-sciences-falls-on-concerns-over-alzheimers-trial?mail_subject=sava-cassava-sciences-falls-on-concerns-over-alzheimer-s-trial&utm_campaign=rta-stock-news&utm_content=link-3&utm_medium=email&utm_source=seeking_alpha

SAVA rebuttal to the claims:

https://seekingalpha.com/pr/18448165-cassava-sciences-responds-to-allegations

Hadn't invested in this yet, now not sure what to do - is this a buying opportunity or a real problem for SAVA? I've owned other bios where clear short attacks turned out to be correct, like NAVB and Marty Shkreli - MRC failed with AMRN, but a different situation, drug was already approved there. The cynic within me says like AMRN/Nissen, somebody big is behind this attack on SAVA - plenty of BPs working on AZ drugs.